Investing carries serious risks, including partial or total loss of capital. Please read the Key Investment Information Sheet and the Risk factors and login before investing.
Faunos
Equity
€159,000
total amount raised in round
- Eligible for a tax reduction
Offer conditions
The FAUNOS 1A compartment of Spreds Finance would participate in the financing of FAUNOS BV/SRL for an amount between €35,000 and €551,000 (the “Capital Increase”).
From the total amount raised during the offering period, Spreds Finance will use €1 per Participatory Note, subject to compliance with the conditions applicable to this investment.
Maximum offer amount: €300,000.
Maximum offer amount: €300,000.
Subscription price: Each Participatory Note has a nominal amount of €1. Added to this is a subscription cost of up to 5% of the nominal amount per Participatory Notes (or €0.05). The total subscription price of a Participatory Note is thus a maximum of €1.05. The minimum subscription amount is €500 (excluding subscription fees).
Conditions precedent of the offering:
The Notes will only be issued if, within 6 months from the Closing Date (the Effective Date), the following cumulative conditions precedent to the subscription of shares by Spreds Finance are met:
The Notes will only be issued if, within 6 months from the Closing Date (the Effective Date), the following cumulative conditions precedent to the subscription of shares by Spreds Finance are met:
- The total amount of firm commitments to subscribe to this capital increase shall be at least €35,000 and not more than €551,000. Contributions in kind are not included in these amounts.
- The Capital Increase is carried out on the basis of a pre-money valuation of the company of maximum €2,520,000.
- Spreds Finance will participate in the capital increase for an amount equal to the result of the subscription to Participatory Notes of the FAUNOS 1A compartment. This amount must be at least €35,000.
Spreds Finance will verify whether these conditions are met no later than six months after the closing date (the “Effective Date”), i.e. 14/06/2027.
If one or more of these conditions are not met on that date, the Notes will not be issued and investors will be reimbursed their subscription amount no later than 15 working days after the Effective Date.
Tax Shelter (45%)
This investment is eligible for a tax reduction for Belgian investors under the tax incentive on tax shelter for start-ups. The reduction of up to 45% of the total nominal amount of the Participatory Notes invested will be applicable since the Underlying Assets are shares in a micro- enterprise. The total tax benefit is therefore a maximum of €0.45 per Participatory Note. The total tax benefit is therefore a maximum of €0.45 per Participatory Note.
The available tax shelter budget is €300,000.
Committed amounts
FAUNOS has received convertible loans.
These loans were concluded between March and July 2026 (principal amount of €100,000, plus accrued interest of €3,657.53 as at 15 December 2026). Mandatory conversion into shares is provided for in the event of a qualified capital increase.
This means that new investors must make a cash contribution of at least €100,000.
In such a case, both the principal amount and the interest will be converted into shares.
It should be noted that the same pre-money valuation will be used for the conversion into shares as that applied to the subscription for shares by Spreds Finance. However, a 20% discount will be applied to this valuation. This is common practice for convertible loans, as the discount compensates lenders for the risk they have taken by making capital available earlier than investors making a cash contribution.
In addition, Elimastri BV/SRL will contribute approximately €100,000 in claims against the company as a contribution in kind. These claims consist of accrued management fees, including VAT, and current-account claims.
This contribution will take place in any event. It will be made at the same pre-money valuation as that applied to the subscription for shares by Spreds Finance. No discount will therefore be applied.
Valuation of the company
The company has set a pre-money valuation of €2.52 million, considering several key elements:
- The company already operates live at 22 locations and 62 installed cameras across breeding farms, a top-level competition stable, veterinary practices in Belgium and a University partner: 11 paying customers who bought the hardware and 11 test locations that we plan to convert. This installed base has already generated hardware sales while also supplying the real-world video data that continuously trains and validates the company's AI models. Growing to 260 customers and a total of 1040 camera subscriptions by the end of 2027 brings us to about €712K ARR in December 2027.
- The underlying technology is built and in use, not conceptual: a proprietary training pipeline for vision models, behavior-detection algorithms, the customer-facing app and pattern recognition are in active use, and the alerting layer is being rolled out. Everything is developed together with veterinarians and researchers, and clinical validation of the foaling models is under way with our clinical partners.
- The company has also secured non-dilutive validation of its technical roadmap through a Flemish government (VLAIO) feasibility study grant of €47,382.50, reducing execution risk on exactly the areas this round is meant to fund. We are applying for a VLAIO R&D project in October 2026.
- Founder-market fit reinforces this: CEO Maarten Verstraeten brings 14+ years of clinical veterinary experience, grounding the product's clinical credibility with the veterinarians and breeders it depends on for adoption. Vinceng Nys has the experience to build and scale a company and has wide expertise in AI and AdTech.
Considering these elements, the company believes that a €2.52M pre-money valuation appropriately reflects Faunos' current stage of development and growth potential.
The €2.52M pre-money valuation includes a 4% employee option pool, so the pool does not dilute new investors.
The round raises up to €551K of new cash (total round €750K, including the convertible loans and the contribution in kind); at that size, new investors and the converting loans together hold about 21% after the round.
In addition, Elimastri BV/SRL converts its claims on the company (accrued management fee including VAT and current-account claims, about €99K) at the round price without discount, representing about 3%.
The founders have already put €107K of their own money into Faunos since incorporation.
On top of that, their unpaid time from June 2025 to May 2027, the part not covered by management fees, will amount to €202K.
The €2.52M pre-money valuation includes a 4% employee option pool, so the pool does not dilute new investors.
The round raises up to €551K of new cash (total round €750K, including the convertible loans and the contribution in kind); at that size, new investors and the converting loans together hold about 21% after the round.
In addition, Elimastri BV/SRL converts its claims on the company (accrued management fee including VAT and current-account claims, about €99K) at the round price without discount, representing about 3%.
The founders have already put €107K of their own money into Faunos since incorporation.
On top of that, their unpaid time from June 2025 to May 2027, the part not covered by management fees, will amount to €202K.
Exit Strategy
For investors, the most likely exit scenario for Faunos would be a strategic acquisition (trade sale) by an established player active in animal health, equine technology, veterinary services, insurance or animal monitoring.
Faunos is building a scalable SaaS platform combining recurring subscription revenues, an installed camera network and a proprietary clinical dataset. As the company expands internationally and clinically validates its foaling, colic and pain detection models, this combination of technology, recurring revenues and unique behavioural data could make Faunos an attractive acquisition target for strategic industry players.
A potential exit is targeted within a 2031–2033 timeframe, once Faunos has reached significant recurring revenue scale, established an international footprint and validated its key monitoring models.
Key KPIs towards exit
KPI 1 — Annual Recurring Revenue (ARR)
- 2026: €0
- 2028: €2.66M
- 2031–2033: €30–40M
KPI 2 — Cameras with Paid Subscriptions
- 2026: 62 cameras
- 2028: 2,840 cameras
- 2031–2033: ~40,000 cameras
KPI 3 — Active Event Venues
- 2026: 0
- 2028: 3 active venues
- 2031–2033: 15–20 active venues across Europe, the US and the Middle East
The exit scenario, timing and KPIs presented above are based on the company’s current business plan and objectives. They are indicative targets only and do not constitute a guarantee of future performance, valuation or exit.
Subscription period
Start date of the offering period: 06/11/2026
Scheduled end date of the subscription period: 14/12/2026
Scheduled end date of the subscription period: 14/12/2026
Extension: Maximum extension of 3 months, until 14/03/2027
Conditions for extension: Spreds Finance may decide to extend the subscription period if the total amount of the orders contained in the subscription forms is at least €28,000 on 14/12/2026.
Early closing: The offer can be closed early once the minimum offer amount, of €35,000, has been reached. Early closure of the offer may also be decided if the total amount of orders contained in the subscription forms signed and transferred to Spreds Finance reaches the maximum amount of the offer.
Consequences if the target capital is not raised by the deadline: If the target capital is not raised, the Participatory Notes will not be issued and all commitments related to this offer will be cancelled. Investors will be reimbursed for their respective Subscription Amount no later than 15 business days after the Deadline. Investors will not incur any fees or expenses as a result of the offer not reaching the targeted amount.
TAX SHELTER 45%
Investments in this company benefit from a 45% personal income tax reduction. Read more…A remaining amount of €242,000 is available for the Tax Shelter benefit.
Raise summary
| Crowd investments | €59,000 |
| Committed by others | €100,000 |
| Amount raised | €159,000 |
| Minimum round | €35,000 |
| Maximum round | €551,000 |
| Shares in the company (total round) | 17.942% |
| Pre-money valuation | €2,520,000 |
| Post-money valuation min. | €2,555,000 |
| Post-money valuation max. | €3,071,000 |